Skip to main content Skip to footer

Disposition of a Clinical Scale Biologics Manufacturing Facility


To package and sell the process facility, a 50,000-square-foot biologics manufacturing facility with two 3,000 Litre Mammalian Cell Manufacturing Sites, back within the industry to a company with a pipeline of products in the clinical stages of development. The facility was already 10 years old at the date of sale.

Identification Strategy

Identify through substantial research the names of those companies who were in Phases I, II and III with a strategy to develop and manufacture their product internally and not contract with a CMO.


35 companies were identified and presented the offering memorandum and detailed drawings. The effort yielded 12 on site visits by interested companies. Three of those companies were vetted and proved to be capable of buying the property and had a specific need for the manufacturing capacity. Within ten months the property was successfully sold to Auxilium Pharmaceutical at a purchase price of $21,250,000 or $425 per square foot.


"Mike Brown and his listing team were on target with their marketing approach and successfully achieved what we thought to be an appropriate purchase price for the property."

Brian Davis 
NEOSE Technologies


Download PDF

Related Experts

Joseph Fetterman

Executive Vice President | Healthcare and Life Sciences


Joe joined Colliers International in 2012 to lead and grow Colliers’ Office Brokerage Division.  Today he focuses on providing strategic solutions to local, national and global Health Care, Life Sciences and Corporate clients. Joe’s background in architecture, real estate development and financial analysis provides clients with an experienced professional and strategic leader who integrates  complex factors to create successful results for clients

Joe is a Healthcare Fellow and serves on Colliers National Healthcare Services and Life Sciences Steering Committees. 

View expert

Michael Brown

Senior Director, Office Services


As the National Leader of Colliers Global Life Science Practice Group, I bring 43 years of commercial real estate experience and 22 years of experience focusing on life science real estate. My acquired knowledge in life science work has been on both the landlord (Wexford Science & Technology) and the tenant side within the industry.

I have experience with Advanced Therapeutic Medicinal Products, Parenteral Fill Finish, Solid Oral Dosage, Biologics, and Medical Device manufacturing facilities, as well as a solid background in Laboratory Research and Development/Pilot scale facilities and controlled environments. Through my work on local, regional and national site selection assignments, I have developed a firm grasp of the rigorous process required to meet the key search criteria of my clients.  

My knowledge of market conditions and influences in the life sciences supports my ability to be creative in structuring the financial details of both lease and purchase transactions. My network of a wide variety of trusted advisors within the industry facilitates a regular flow of information about life science real estate trends, pricing, and comparable data for leasing and sales transactions.

Personal Goal:

To make sure that our team can deliver insightful and thoughtful life science real estate strategies to our clients, regardless of company size and the challenges they may face in entering and exiting the clinic successfully.

View expert